complaint
rhiniti
one
frequent
reason
patient
seek
physician
evalu
rhiniti
inflammatori
respons
nasal
mucosa
variou
stimuli
allerg
nonallerg
character
symptom
nasal
congest
sneez
nasal
pruriti
r
h
nr
r
h
e
preval
rhiniti
econom
impact
patient
manag
care
organ
dictat
clinician
care
consid
medic
avail
rhiniti
account
estim
million
offic
visit
almost
upper
respiratori
tract
infect
london
patient
seen
allerg
rhiniti
perenni
symptom
perenni
season
corn
plaint
like
time
onset
allerg
symptom
age
allerg
rhiniti
student
highest
preval
patient
age
likelihood
develop
allerg
rhiniti
declin
mani
reason
increas
preval
allerg
rhiniti
past
year
recent
attent
drawn
role
dieselexhaust
particl
induc
ige
product
increas
mrna
mani
cytokin
stimul
ige
product
addit
increas
interleukin
protein
found
nasal
lavag
intranas
challeng
diesel
may
one
reason
children
possibl
risk
factor
develop
allerg
rhiniti
age
year
includ
matern
smoke
least
pack
per
day
parent
histori
atopi
ingest
food
formula
breast
milk
age
month
presenc
dog
indoor
estim
cost
allerg
rhiniti
exceed
billion
per
year
direct
medic
physician
indirect
time
work
c
ss
allerg
rhiniti
alon
account
miss
workday
miss
school
day
reduc
activ
day
accord
physician
audit
databas
data
estim
prescript
antihistamin
account
million
intranas
corticosteroid
million
prescript
cold
medicin
million
consider
profound
econom
impact
rhiniti
patient
imper
clinician
consid
pathophysiolog
differenti
diagnos
rhiniti
choos
appropri
therapi
patient
allerg
rhiniti
sensit
occur
process
foreign
antigen
antigenpres
cell
present
thelper
cell
cell
produc
cytokin
promot
stimul
b
cell
produc
ige
specif
antigen
allergen
two
ige
antibodi
crosslink
bind
specif
epitop
allergen
degranul
attach
fc
receptor
mast
cell
occur
result
mediat
releas
allerg
reaction
exhibit
biphas
respons
character
releas
prostaglandin
pg
tosyllarginin
methyl
esteras
tameesteras
kinin
histamin
immedi
mast
cell
mediat
except
pgd
basophil
hour
later
cytokin
promot
ige
mast
cell
prodction
addit
promot
product
ige
wherea
gamma
interferon
oppos
ige
prod
ut
n
mast
cell
also
enhanc
ige
product
produc
inflammatori
cell
recruit
area
cytokin
releas
also
monocyt
chemotact
activ
factor
mcaf
monocyt
chemoattract
mcpl
chemokin
known
rant
regul
normal
cell
express
secret
macrophag
inflammatori
proteinla
mipla
activ
basophil
mcafrant
eosinophil
rantesmipla
wherea
inhibit
mcafinduc
histamin
releas
increas
cd
lymphocyt
cdposit
activ
cell
seen
nasal
prime
effect
result
increas
mastcel
densiti
continu
season
allergen
challeng
result
histamin
releas
sneez
nasal
ocular
pruritu
result
pruritu
may
felt
soft
palat
also
well
refer
ear
along
eustachian
tube
nasal
congest
result
histamin
releas
act
vasodil
turbin
effect
leukotrien
prostaglandin
nasal
mucosa
compon
nasal
secret
includ
antibodi
especi
iga
macroglobdin
lactoferrin
lysozym
mucu
cell
glycoprotein
histamin
also
activ
glandular
hypersecret
via
nocioceptiveparasympathet
reflex
produc
mucu
nonallerg
stimul
affer
pathway
nasal
sensori
receptor
result
cholinerg
stimul
via
effer
pathway
nasal
goblet
cell
result
rhinorrhea
major
result
rhinorrhea
propel
backward
cilia
nasal
caviti
toward
pharynx
postnas
drip
excess
secret
drain
deciph
allerg
nonallerg
reason
rhiniti
difficult
especi
viral
infect
may
occur
height
allergi
season
mani
elderli
patient
convinc
allergi
pseudoallerg
respons
gustatori
vasomotor
rhiniti
compound
confus
mani
patient
experi
evalu
practition
inadequ
train
properli
test
immedi
ige
mediat
hypersensit
perpetu
patient
percept
allergi
histori
patient
relat
use
tool
suggest
allerg
caus
symptom
histori
differenti
allerg
nonallerg
caus
summar
tabl
season
allergi
correspond
pollenosi
windpollin
plant
wherea
perenni
allergi
yearround
caus
mostli
indoor
allergen
typic
spring
allergen
caus
tree
pollen
latespr
summer
symptom
grass
pollen
fall
symptom
weed
pollenosi
indoor
anim
feather
pillow
contain
dust
mite
rainfal
humidityincreas
mold
exposur
well
cockroach
exposur
elicit
symptom
consist
perenni
allerg
rhiniti
food
allergi
rare
sourc
allerg
rhiniti
adult
physic
find
vari
depend
sever
allerg
reaction
rhinorrhea
typic
clear
although
occasion
densiti
eosinophil
neutrophil
impart
yellowtogreen
color
secret
turbin
may
appear
pale
slightli
blue
cyanot
clear
secret
transvers
creas
may
result
child
rub
anterior
portion
nose
upward
allerg
salut
persist
postnas
drainag
may
induc
lymphoid
follicular
hyperplasia
posterior
pharynx
cobbleston
appear
ocular
sign
vari
intens
mild
conjunctiv
erythema
mark
cobbleston
inner
eyelid
edema
eyelid
may
occur
especi
patient
rub
eye
repeatedli
chemosi
occur
result
swell
limbu
around
iri
final
allerg
shiner
appear
dark
circl
eye
caus
vascular
congest
venou
drainag
nose
laboratori
evalu
determin
caus
limit
stain
nasal
secret
eosinophil
hansel
stain
suggest
caus
specif
allerg
r
h
n
irrit
rhiniti
well
infecti
rhiniti
produc
neutrophil
predominantli
total
ige
level
complet
blood
cell
count
insuffici
predict
whether
patient
allerg
use
screen
tool
skin
test
radioallergosorb
rast
test
use
confirm
suspicion
reli
make
diagnosi
labil
allergen
use
skin
test
well
variabl
skin
test
respons
interpret
test
perform
boardcertifi
allergist
experienc
recogn
condit
produc
falseposit
reaction
intraderm
test
limit
overinterpret
test
result
concentr
elicit
irrit
respons
likewis
overreli
mildli
posit
rast
result
diagnosi
therapi
may
erron
perpetu
notion
allergi
patient
fals
impress
longlast
patient
desir
diagnosi
complaint
final
provocationneutr
test
set
endpoint
titrat
rast
igg
specif
food
antigen
candida
controversi
shown
provid
reliabl
evid
allergyloo
nonallerg
rhiniti
eosinophila
syndrom
nare
character
sneez
paroxysm
nasal
pruriti
copiou
clear
rhinorrhea
stain
posit
eosinophil
although
physic
exam
may
suggest
allergi
skin
test
exclus
studi
evalu
patient
neg
skin
test
patient
nare
base
nasal
smear
reveal
greater
nasal
eosinophil
vasomotor
r
h
n
likewis
patient
nasal
polyposi
may
nasal
eosinophilia
major
due
viral
upper
respiratori
tract
infect
account
major
case
rhiniti
report
patient
rhinovirus
implic
frequent
other
includ
respiratori
syncyti
viru
coronavirus
within
day
nasal
obstruct
rhinorrhea
sneez
sore
scratchi
throat
clue
viral
origin
serial
transmiss
persontoperson
seen
spous
well
greater
incid
affect
patient
commun
expect
allergi
typic
one
five
patient
latter
predomin
cell
nasal
smear
rhinoviru
infect
includ
polymorphonuclear
leukocyt
rare
desquam
ciliat
epitheli
cell
although
kinin
increas
symptomat
patient
rhinoviru
infect
signific
increas
either
histamin
prostaglandin
pgd
nasal
reason
firstgener
antihistamin
shown
rel
littl
efficaci
symptom
control
except
anticholinerg
sideeffect
dri
mucosa
rhinovirus
bind
cell
via
receptor
known
intercellular
adhes
molecul
icaml
play
promin
role
inflammatori
respons
symptom
viral
infect
usual
improv
within
day
symptom
worsen
initi
clear
secondari
bacteri
sinus
consid
multitud
physic
stimuli
affect
nasal
symptom
increas
nasal
resist
caus
hyperventil
chronic
stress
skin
pressur
later
recumb
ipsilater
side
sexual
arous
warm
temperatur
circadian
variat
sneez
nasal
congest
rhiniti
wors
earli
morn
compar
time
day
exercis
decreas
nasal
congest
factor
includ
rapid
chang
temperatur
humid
bright
light
elicit
nasal
symptom
vasomotor
instabl
gustatori
rhiniti
occur
patient
report
clear
rhinorrhea
eat
food
like
either
hot
spici
food
irrit
rhiniti
result
stimul
nasal
receptor
odor
dust
particl
smoke
induc
clear
rhinorrhea
result
sneez
nasal
congest
gustatori
irrit
rhiniti
mediat
parasympathet
sever
medic
contribut
nasal
symptom
nasal
congest
produc
betablock
terazosin
reserpin
methyldopa
oral
contracept
aspirin
nonsteroid
antiinflammatori
nsaid
agent
promot
rhiniti
associ
triad
asthma
nasal
polyposi
aspirin
hypersensit
asthma
igemedi
perhap
best
known
side
effect
rebound
nasal
congest
occur
abus
topic
nasal
decongest
rhiniti
medicamentosa
exactli
patient
prone
develop
rebound
congest
unknown
typic
patient
notic
use
topic
decongest
frequent
shorter
durat
relief
cocain
abus
also
consid
especi
patient
present
rhiniti
associ
nasal
septal
perfor
among
condit
contribut
rhiniti
nasal
congest
hypothyroid
diabet
mellitu
pregnanc
pregnanc
particularli
problem
women
effect
progesteron
vascular
bed
nasal
turbin
promot
uncomfort
congest
rare
condit
may
caus
rhiniti
includ
sarcoidosi
wegen
granulomatosi
rhinoscleroma
cerebrospin
fluid
rhinorrhea
obstruct
caus
septal
deviat
well
foreign
bodi
nasal
polyp
consid
caus
refractori
nasal
congest
rhinorrhea
children
adenoid
hypertrophi
play
role
persist
congest
snore
cough
rhiniti
elderli
patient
also
suscept
rhiniti
thin
nasal
mucosa
atroph
rhiniti
left
untreat
patient
rhiniti
develop
seriou
medic
problem
patient
asthma
upperairway
obstruct
significantli
greater
improv
airflow
limit
intranas
beclomethasonelo
likewis
treatment
intranas
steroid
prevent
increas
airway
hyperrespons
methacholin
challeng
allergi
patient
obstruct
sleep
apnea
found
increas
obstruct
apnea
indic
obstruct
apnea
durat
nasal
resist
ragwe
season
allerg
rhiniti
infecti
complic
otiti
media
sinus
occur
greater
frequenc
nonallerg
origin
rhiniti
viral
upperrespiratori
tract
infect
also
contribut
increas
airway
hyperreact
asthmat
also
patient
allerg
prescrib
medic
physician
awar
cost
limit
indic
prescrib
nonsed
antihistamin
patient
copiou
rhinorrhea
viral
caus
effect
one
studi
nasal
steroid
prescrib
nonallerg
rhiniti
almost
frequent
allerg
rhiniti
treatment
allerg
rhiniti
stepwis
approach
consid
base
symptom
score
patient
need
antihistamin
hi
antagonist
effect
competit
block
effect
histamin
nasal
ocular
mucosa
thu
control
pruriti
sneez
firstgener
antihistamin
lipophil
cross
bloodbrain
barrier
induc
vari
degre
anticholinerg
side
effect
includ
sedat
dri
secret
extend
releas
prepar
quit
effect
fact
brompheniramin
may
provid
compar
relief
symptom
compar
terfenadin
newer
secondgener
antihistamin
provid
relief
minimum
side
effect
cross
bloodbrain
barrier
lessor
nonsed
decreas
anticholinerg
properti
allow
use
instanc
sinu
infect
occur
allergi
excess
dri
nasal
mucosa
undesir
suppress
histamineinduc
cutan
respons
superior
also
well
toler
toler
appear
develop
prolong
major
secondgener
antihistamin
antiinflammatori
proper
tie
terfenadin
inhibit
histamin
releas
basophil
loratadin
decreas
alpha
macroglobulin
nasal
loratadin
azelastin
hydrochlorideg
inhibit
product
leukotrien
lt
neutrophil
eosinophil
respect
cetirizingl
azelastinea
also
prevent
product
ltb
kiningl
product
also
inhibit
azelastin
cetirizin
inhibit
migrat
eosinophil
neutrophil
skin
skin
test
earlyand
latephas
eosinophil
neutrophil
number
reduc
express
suppress
cetirizin
conjunctiv
challeng
cetirizin
also
reduc
migrat
monocyt
lymphocyt
respons
chemotact
factor
fmlp
ltb
secondgener
antihistamin
also
advantag
lessfrequ
dose
well
rapid
onset
action
fexofenadin
allegra
hoechst
marian
roussel
kansa
citi
mo
azelastin
aztelin
wallac
laboratori
cranburi
nj
effect
use
twice
day
terfenadin
seldan
hoechst
marian
roussel
kansa
citi
mo
target
remov
food
drug
administr
fda
cardiac
side
effect
patient
use
medic
interfer
terfenadin
metabol
congenit
qt
prolong
liver
dysfunct
astemizol
hisman
janssen
pharmaceutica
titusvil
nj
given
day
similar
sideeffect
profil
avail
activ
metabolit
fexofenadin
terfenadin
loratadin
claritin
schere
corpor
kenilworth
nj
given
daili
avail
pseudoephedrin
decongest
cetirizin
zyrtec
pfizer
inc
new
york
ny
less
sedat
parent
compound
azelastin
astelin
nasal
spray
administ
twice
day
anoth
topic
antihistamin
levocabastin
livostin
ciba
vision
ophthalm
atlanta
ga
avail
eye
drop
effect
also
intrana
although
antihistamin
use
suppress
histamin
respons
ineffect
relief
nasal
congest
adrenerg
receptor
alpha
act
vasoconstrictor
therefor
decreas
blood
flow
turbin
pseudoephedrin
phenylpropanolamin
phenylephrin
commonli
use
decongest
ad
antihistamin
clinician
consid
drug
interact
tricycl
antidepress
monoamin
oxidas
inhibitor
side
effect
insomnia
palpit
medic
condit
may
contraind
usag
pregnanc
hypertens
prescrib
combin
therapi
although
topic
decongest
effect
relief
nasal
congest
use
limit
longer
day
order
prevent
rhiniti
medicamentosa
intranas
ipratropium
bromid
atrov
boehring
ingelheim
pharmaceut
ridgefield
ct
use
nonallerg
rhiniti
treatment
result
reduct
rhinorrhea
nonallerg
rhiniti
without
sedat
ipratropium
bromid
also
reduc
need
agent
treat
perenni
r
h
n
ipratropium
bromid
effect
control
rhinorrhea
associ
common
also
shown
safe
effect
children
older
age
year
treat
perenni
nonallerg
rhiniti
pg
per
nostril
twice
day
howev
ipratropium
effect
reliev
nasal
congest
modifi
allerg
reaction
cromolyn
sodium
nasalcrom
pharmacia
upjohn
kalamazoo
mi
mastcel
stabil
block
releas
histamin
although
avail
overthecount
must
use
regularli
four
time
day
pretreat
prevent
immediateand
latephas
allerg
respons
use
regularli
cromolyn
sodium
decreas
symptom
score
rhinorrhea
nasal
congest
prove
superior
terfenadin
earli
allergi
intranas
nedocromil
also
shown
decreas
mastcel
allergi
intranas
corticosteroid
extrem
effect
treatment
allerg
inflamm
promot
vasoconstrict
decongest
decreas
capillari
permeabl
glandular
respons
cholinerg
stimuli
reduc
secret
reduc
mediat
product
releas
inhibit
influx
inflammatori
cell
eosinophil
basophil
nasal
epithelim
intranas
fluticason
propion
flonas
glaxowellcom
inc
research
triangl
park
nc
ygd
significantli
decreas
amount
granulocyt
macrophag
coloni
stimul
factor
gmcsf
mipla
rant
releas
within
hour
allergen
intranas
corticosteroid
inhibit
transcript
cytokin
evid
decreas
express
given
either
prechalleng
shortli
challeng
allergen
intranas
budesonid
rhinacort
rhinocort
astra
usa
inc
wayn
pa
rapidli
effect
decreas
immedi
hypersensit
mediat
releas
tame
activ
within
week
continu
use
intranas
corticosteroid
also
inhibit
earli
mediat
releas
symptom
corticosteroid
use
start
patient
symptoma
provid
relief
compar
loratadin
less
week
intranas
fluticason
propion
ygd
produc
greater
relief
nasal
congest
peak
inspiratori
flow
also
oncedaili
administr
triamcinolon
acetonid
nasacort
rhonepoulnec
rorer
pharmaceut
inc
collegevil
pa
ygd
superior
astemizol
mgd
relief
nasal
congest
nasal
itch
snee
contrast
nasal
steroid
mometason
furoat
nasonex
schere
pharmaceut
kenilworth
nj
exhibit
dose
respons
curv
pgd
provid
best
studi
demonstr
compar
efficaci
flunisolid
nasarel
nasalid
dura
pharmaceut
san
diego
ca
fluticason
propion
mcgday
beclomethason
dipropion
vancenas
schere
pharmaceut
kenilworth
nji
beconas
glaxowellcom
inc
research
triangl
park
nci
appear
signific
differ
effect
among
nasal
steroid
inhibit
r
h
n
nasal
steroid
side
effect
mostli
intermitt
epistaxi
rare
nasal
necrosi
report
longterm
studi
beclomethason
dipropion
show
evid
mucos
atroh
inhal
corticosteroid
may
effect
growth
rate
shown
littl
ygd
budesonid
similar
effect
shortterm
growth
measur
knemometri
mg
methylprednisolon
acet
im
use
direct
increas
risk
intraocular
pressur
note
nasal
cataract
report
elderli
patient
cumul
dose
least
mg
beclomethason
current
user
although
control
previou
system
corticosteroid
use
well
previou
current
use
inhal
corticosteroid
trend
ignific
oral
steroid
inject
steroid
may
provid
rapid
relief
allerg
symptom
reduc
latephas
mediat
product
howev
risk
asept
necrosi
hip
cataract
frequenc
use
limit
patient
refractori
medic
use
oral
prednison
although
effect
reduc
kinin
format
experiment
rhinoviru
infect
differ
placebo
decreas
nasal
secret
volum
symptom
frequent
overlook
manag
allerg
nonallerg
rhiniti
avoid
allergen
irrit
although
common
sens
dictat
patient
abl
recogn
caus
factor
rhiniti
reinforc
physician
help
acknowledg
avoid
techniqu
instanc
cat
lover
often
accus
friend
rel
cat
caus
symptom
never
cat
likewis
smoker
reluct
acknowledg
effect
smoke
irrit
patient
pollen
allerg
avoid
outdoor
activ
peak
pollin
period
keep
door
window
close
spring
fall
pollen
period
help
patient
dustmit
allerg
benefit
avoid
feather
product
zipper
vinyl
encas
mattress
box
spring
lay
carpet
surfac
lmmunotherapi
allergi
shot
consid
patient
despit
optim
environment
control
medic
still
qualiti
life
compromis
allergi
symptom
skin
test
use
confirm
allergist
impress
justifi
put
patient
immunotherapi
risk
anaphylaxi
death
immunotherapi
administ
medic
facil
equip
handl
emerg
patient
allerg
rhiniti
overal
feel
qualiti
life
wors
compar
gener
popul
allerg
patient
feel
fatigu
physic
limit
decreas
social
function
increas
pain
overal
poorer
imag
compar
nonatop
patient
measur
rhinoconjunct
qualiti
life
questionnair
rqlq
u
patient
rhiniti
also
experi
signific
percept
side
effect
medic
avoid
drug
side
effect
worri
side
effect
medic
patient
frequent
complain
decreas
energi
possibl
caus
medic
side
effect
sedat
insomnia
symptom
medic
interf
sleep
cycl
headach
allergi
usual
result
hypertrophi
turbin
sinu
inflamm
upward
patient
rhiniti
may
headach
referr
discomfort
frontal
sinu
distribut
except
sinus
foodinduc
migrain
discomfort
frontal
sinu
distribut
major
headach
allerg
origin
caus
percept
poor
health
patient
chronic
rhiniti
may
refractori
standard
treatment
patient
may
assum
sens
heighten
awar
vigil
tri
avoid
odor
chemic
perceiv
threatenirg
may
convinc
plight
anecdot
report
obtain
altern
controversi
health
care
provid
internet
mani
patient
underli
psycholog
reason
comp
l
n
patient
present
sever
symptom
proport
object
evid
last
longer
month
refractori
optim
medic
environment
control
diagnosi
undifferenti
somatoform
disord
consid
prescrib
medic
keep
side
effect
profil
mind
especi
consid
sedat
patient
requir
mental
alert
twentyf
milligram
hydroxyzin
twice
day
shown
significantli
prolong
reaction
time
computerbas
eyehand
test
induc
sedat
compar
take
mg
terfenadin
twice
day
bind
dopamin
serotonin
muscarin
histamin
receptor
shown
occur
hydroxyzin
compar
bind
histamin
receptor
patient
take
mg
hydroxyzin
made
fewer
correct
respons
simul
assembl
line
task
compar
subject
take
cetirizin
sedat
cetirizin
dose
depend
signific
sedat
howev
comparison
mg
mg
cetirizin
significantli
differ
induc
somnol
studi
document
learn
problem
associ
allergi
sedat
medic
children
season
allerg
rhiniti
show
smaller
increas
conceptu
knowledg
learn
compar
normal
control
effect
improv
loratadin
yet
worsen
use
similar
result
also
seen
young
adult
acrivastin
versu
studi
occup
injuri
especi
burn
fractur
wound
worker
like
taken
sedat
antihistamin
month
prior
injuri
drive
perform
studi
subject
take
triprolidin
exhibit
significantli
wors
drive
skill
compar
take
terfenadinep
although
secondgener
antihistamin
may
offer
addit
antihistamin
benefit
older
hi
antagonist
may
expens
consid
safer
sedat
astemizol
terfenadin
metabol
isoenzym
cytochrom
enzym
system
liver
given
medic
competit
use
metabol
macrolid
antibiot
imidazol
antifung
nefazodon
fluvoxamin
increas
blood
level
occur
result
risk
torsad
de
point
despit
warn
drug
interact
combin
use
contraind
drug
terfenadin
demonstr
similar
problem
may
occur
patient
prolong
qt
interv
hypokalemia
liver
dysfunct
overdos
fexofenadin
allegra
hoechst
marion
roussel
kansa
citi
mo
carboxylicacidact
metabolit
terfenadin
appear
signific
cardiac
side
use
medic
pregnanc
pose
risk
fetal
malform
choos
medic
safer
profil
addit
inform
patient
avail
altern
option
reason
approach
base
collabor
perinat
project
medic
implic
fetal
malform
includ
brompheniramin
phenylpropanolamin
phenylephrin
hydroxyzin
chlorpheniramin
tripelennamin
recommend
antihistamin
consid
although
design
categori
c
medic
inhal
corticosteroid
implic
increas
incid
fetal
malform
asthmat
likewis
cromolyn
sodium
increas
risk
fetal
malform
asthmat
patient
patient
rhiniti
significantli
improv
qualiti
live
use
medic
environment
control
allerg
caus
immunotherapi
cost
medic
stepwis
approach
similar
asthma
nation
heart
lung
blood
instituten
asthma
educ
prevent
program
guidelin
provid
effici
costeffect
program
manag
rhiniti
tabl
outlin
exampl
plan
earli
recognit
caus
rhiniti
well
confound
factor
contribut
recurr
allergi
versu
deviat
instanc
help
manag
prevent
futur
episod
whether
allerg
nonallerg
rhiniti
character
copiou
amount
clear
drainag
best
treat
initi
antihistamin
anticholinerg
side
effect
viralinduc
rhiniti
refractori
antihistamin
intranas
ipratropium
bromid
nasal
salin
lavag
may
provid
relief
patient
excess
purul
dri
secret
aggrav
nasal
congest
especi
patient
sinus
treatment
allerg
rhiniti
patient
may
benefit
initi
asneed
antihistamin
especi
lessor
nonsed
allerg
rhiniti
establish
pattern
symptom
perenni
season
exacerb
treatment
intranas
corticosteroid
consid
first
supplement
antihistamin
need
ocular
symptom
refractori
corticosteroid
reduc
inflammatori
respons
intranas
corticosteroid
superior
antihistamin
must
use
regularli
achiev
likewis
intranas
azelastin
requir
continu
treatment
compar
ondemand
achiev
antiinflammatori
effect
nasal
polyp
complic
allerg
rhiniti
intranas
fluticason
benefici
j
treatment
rhiniti
base
consider
differenti
diagnos
well
appropri
therapi
caus
nonallerg
rhiniti
includ
infecti
irrit
structur
vasomotor
stimuli
allerg
rhiniti
character
pruriti
caus
histamin
releas
along
sneez
clear
rhinorrhea
nasal
congest
allerg
rhiniti
typic
affect
popul
associ
histori
consist
immedi
hypersensit
famili
histori
variou
releas
mediat
histamin
medic
requir
treatment
allerg
rhiniti
focu
control
inflammatori
respons
intranas
corticosteroid
effect
although
newer
lessor
nonsed
antihistamin
antiinflammatori
properti
side
effect
medic
infrequ
need
consid
prescrib
avoid
techniqu
allergen
exposur
also
need
follow
patient
qualiti
life
compromis
despit
optim
medic
environment
control
immunotherapi
consid
improv
patient
qualiti
life
decreas
morbid
associ
chronic
rhiniti
major
consider
prescrib
